Gene · 10935
Papers2,082
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,082
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanism of KAT2A regulation of H3K36ac in manganese-induced oxidative damage to mitochondria in the nervous system and intervention by curcumin. | Ecotoxicol Environ Saf | 2024 | 38417317 | PubTator, text mining | PubMed |
| IC3D Classification of Corneal Dystrophies-Edition 3. | Cornea | 2024 | 38359414 | PubTator, text mining | PubMed |
| Peroxiredoxin 3 regulates breast cancer progression via ERK-mediated MMP-1 expression. | Cancer Cell Int | 2024 | 38321552 | PubTator, text mining | PubMed |
| Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells. | Biochem Biophys Rep | 2024 | 38288281 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Development-Specific Networks at Distinct Synchronized Antral Follicle Sizes in Sheep Oocytes. | Int J Mol Sci | 2024 | 38255985 | PubTator, text mining | PubMed |
| The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | 38254783 | PubTator, text mining | PubMed |
| Unraveling the causes of sarcopenia: Roles of neuromuscular junction impairment and mitochondrial dysfunction. | Physiol Rep | 2024 | 38225199 | PubTator, text mining | PubMed |
| A novel specific ferroptosis marker PRDX3: A hero or a villain in clear-cell renal cell carcinoma? | Asian J Surg | 2024 | 38220529 | PubTator, text mining | PubMed |
| Novel diagnostic biomarkers of oxidative stress, ferroptosis, immune infiltration characteristics and experimental validation in ischemic stroke. | Aging (Albany NY) | 2024 | 38198162 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase TRIM39 modulates renal fibrosis induced by unilateral ureteral obstruction through regulating proteasomal degradation of PRDX3. | Cell Death Discov | 2024 | 38195664 | PubTator, text mining | PubMed |
| RNA m6A methylation regulators in liver cancer. | Cancer Cell Int | 2024 | 38166832 | PubTator, text mining | PubMed |
| USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma. | Cancer Lett | 2024 | 38097136 | PubTator, text mining | PubMed |
| Identification of sulfhydryl-containing proteins and further evaluation of the selenium-tagged redox homeostasis-regulating proteins. | Redox Biol | 2024 | 38064764 | PubTator, text mining | PubMed |
| FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction. | Eur J Cancer | 2024 | 37988843 | PubTator, text mining | PubMed |
| ESYT1 tethers the ER to mitochondria and is required for mitochondrial lipid and calcium homeostasis. | Life Sci Alliance | 2024 | 37931956 | PubTator, text mining | PubMed |
| Quantitative Chemical Proteomics Reveals Triptolide Selectively Inhibits HCT116 Human Colon Cancer Cell Viability and Migration Through Binding to Peroxiredoxin 1 and Annexin A1. | Adv Biol (Weinh) | 2024 | 37794608 | PubTator, text mining | PubMed |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| In vivo imaging of astrocytes in the whole brain with engineered AAVs and diffusion-weighted magnetic resonance imaging. | Mol Psychiatry | 2024 | 35484244 | PubTator, text mining | PubMed |
| Mitochondrial H2O2 Is a Central Mediator of Diclofenac-Induced Hepatocellular Injury. | Antioxidants (Basel) | 2023 | 38275637 | PubTator, text mining | PubMed |
| Distinct or Overlapping Areas of Mitochondrial Thioredoxin 2 May Be Used for Its Covalent and Strong Non-Covalent Interactions with Protein Ligands. | Antioxidants (Basel) | 2023 | 38275635 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10935/papers?page=6